Literature DB >> 8768770

An analysis of the conserved residues between halobacterial retinal proteins and G-protein coupled receptors: implications for GPCR modeling.

T G Metzger1, M G Paterlini, P S Portoghese, D M Ferguson.   

Abstract

An alignment of the transmembrane domains of halobacterial retinal proteins (including bacteriorhodopsin) and G-protein coupled receptors (GPCRs) is presented based on the commonality of conserved residues between families. Due to the limited sequence homology displayed by these proteins, an alternative strategy is proposed for sequence alignment that correlates residues within secondary structure elements. The nonsequential alignment developed identifies three proline and two aspartates residues that share common positions and, in the former case, similar functions in the transmembrane domain. The alignment is further applied to model the packing of transmembrane helices 5 and 6 of the beta-adrenergic receptor based on the backbone coordinates of bacteriorhodopsin helices 3 and 2, respectively. Unlike models derived from standard sequential alignments, the approach developed here allows the key structural features conferred by the proline residues to be captured during model building. The structure described is also compared with available site directed mutagenesis results as well as existing GPCR models. In addition to the implications to model building, the commonality observed suggests a potential relationship among the GPCRs and retinal proteins.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8768770     DOI: 10.1021/ci950360j

Source DB:  PubMed          Journal:  J Chem Inf Comput Sci        ISSN: 0095-2338


  2 in total

Review 1.  Homology modeling of opioid receptor-ligand complexes using experimental constraints.

Authors:  Irina D Pogozheva; Magdalena J Przydzial; Henry I Mosberg
Journal:  AAPS J       Date:  2005-10-05       Impact factor: 4.009

2.  An empirical test of convergent evolution in rhodopsins.

Authors:  Kristine A Mackin; Richard A Roy; Douglas L Theobald
Journal:  Mol Biol Evol       Date:  2013-09-27       Impact factor: 16.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.